菜单

Supply Chain Intelligence about:

Novartis Farmaceutica SA De Cv

企业页面   Mexico

See Novartis Farmaceutica SA De Cv's products and customers

成千上万家像您这样的公司使用磐聚网搜索供应商和竞争对手。

轻松使用贸易数据

Explore trading relationships hidden in supply chain data

Contact information for Novartis Farmaceutica SA De Cv

 
地址
TLALPAN/1779//SN DIEGO CHURUBUSCO/COYOACAN DF/20 AGOSTO Y HEROES DEL 47 CUAJIMALPA DE MORELOS DISTRITO FEDERAL 4120
 
 

Sample Bill of Lading

11,443 shipment records available

Bill of Lading Number
3006084
Shipment Date
2023-04-25
Consignee
Labcorp Central Laboratory Services Lp
Consignee (Original Format)
LABCORP CENTRAL LABORATORY SERVICES LIMITED PARTNERSHIP
Consignee Registration Number
351937506
Shipper
Novartis Farmaceutica SA De Cv
Shipper (Original Format)
NOVARTIS FARMACEUTICA SA DE CV INSURGENTES SUR 2475 LORETO Y EJE 10 CIUDAD DE MEXICO, 01090 Mexico
Shipper Tax Number
NFA971101EDA
Shipment Destination
["United States"]
Port of Lading
Ciudad de México (MX)
Port of Lading (Original Format)
AEROPUERTO INTERNACIONAL DE LA CIUDAD DE MEXICO,AEROPUERTO INTERNACIONAL DE LA CIUDAD DE MEXICO
Country of Purchase
United States
Transport Method
Air
Customs Regime
Final Import / Export
Customs Agent
3467
Gross Weight (kg)
18.0
Gross Weight (t)
0.018
Gross Weight (Original Format)
18.0
Value of Goods, CIF (USD)
$62
Value of Goods, CIF (MXN)
1116
Exchange Rate (MXN-USD)
$18
Item Destination
United States
Industry - GICS
[#<GicsCode id: 183, gics_code: "35201010", created_at: "2020-07-16 09:56:29", updated_at: "2020-07-16 09:56:30", description: "Biotechnology">]
HS Code
3001209900
Goods Shipped
XXXXX XXXXXX
Shipment Quantity
18.0
Shipment Unit
Pieza
Value of Goods, Item CIF (USD)
$18
Value of Goods, Item CIF (MXN)
324
Shipment Value (MXN)
324
Tax Quantity
0.18
Tax Unit
Kilo
Customs Processing Tax 1 Value (MXN)
409

Recent Panjiva Research about Novartis Farmaceutica SA De Cv

20161123-uk-ppi

The Old Ones Are the Best Ones as P-PI Drug Imports Grow

U.S. imports of proton-pump inhibitor drugs to treat gastrointestinal disease increased 45% in October on a year earlier, a similar rate to that seen for statins and anticonvulsants. Around half the growth in the three months to October 31 vs. the same period a year earlier came from omeprazol... Read more →